To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04848337
Title Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer (PLANE-PC)
Acronym PLANE-PC
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Ulka Vaishampayan
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Winship Cancer Instituted of Emory University Atlanta Georgia 30322 United States Details
University of Michigan Health System Ann Arbor Michigan 48109 United States Details
Oregon health Portland Oregon 97239 United States Details
Froedtert and The Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field